Literature DB >> 12057132

Phyllodes tumors of the breast.

S A Khan1, S Badve.   

Abstract

Phyllodes tumor is a rare fibroepithelial neoplasm of the breast with a very variable, but usually benign, course. Formerly known as cystosarcoma phyllodes, the designation "phyllodes tumor" with appropriate qualification regarding malignant potential based on pathologic features is now the agreed-upon term. The most important diagnostic distinction is from fibroadenoma--phyllodes tumors require complete excision with free margins even when pathologic features suggest benignity because of a proclivity to local recurrence. The most important component of therapy is wide surgical excision, and mastectomy is necessary only when free margins cannot be achieved without it. Involvement of axillary nodes is rare, and axillary dissection is not indicated. The role of radiation therapy and chemotherapy is not established and has not been studied in randomized trials due to the rarity of the tumor. At present, there is no consensus that patients with high-grade phyllodes tumors of the breast will benefit from either of these modalities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12057132     DOI: 10.1007/s11864-001-0056-y

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  31 in total

1.  The extent of surgery and prognosis of patients with phyllodes tumor of the breast.

Authors:  C Zissis; N Apostolikas; A Konstantinidou; J Griniatsos; P P Vassilopoulos
Journal:  Breast Cancer Res Treat       Date:  1998-04       Impact factor: 4.872

2.  Immunohistochemical study of MIB1 expression in phyllodes tumor and fibroadenoma.

Authors:  Y Umekita; H Yoshida
Journal:  Pathol Int       Date:  1999-09       Impact factor: 2.534

3.  Factors leading to local recurrence or death after surgical resection of phyllodes tumours of the breast.

Authors:  W K de Roos; P Kaye; D M Dent
Journal:  Br J Surg       Date:  1999-03       Impact factor: 6.939

4.  Technetium-99m-sestamibi scintimammography of benign and malignant phyllodes tumors.

Authors:  H Ohta; T Komibuchi; T Nishio; T Kitai; S Yamamoto; M Ukikusa; H Awane; K Irie; M Shintaku
Journal:  Ann Nucl Med       Date:  1997-02       Impact factor: 2.668

5.  Mammary fibroadenoma and some phyllodes tumour stroma are composed of CD34+ fibroblasts and factor XIIIa+ dendrophages.

Authors:  J S Silverman; A Tamsen
Journal:  Histopathology       Date:  1996-11       Impact factor: 5.087

6.  Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre.

Authors:  J F Stebbing; A G Nash
Journal:  Ann R Coll Surg Engl       Date:  1995-05       Impact factor: 1.891

7.  Adjuvant radiotherapy for phyllodes tumor of breast.

Authors:  A W Chaney; A Pollack; M D McNeese; G K Zagars
Journal:  Radiat Oncol Investig       Date:  1998

8.  Phyllodes tumor of the breast. An immunohistochemical study of 28 cases with special attention to the role of myofibroblasts.

Authors:  F I Aranda; J B Laforga; J I López
Journal:  Pathol Res Pract       Date:  1994-05       Impact factor: 3.250

Review 9.  Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases.

Authors:  C J Moffat; S E Pinder; A R Dixon; C W Elston; R W Blamey; I O Ellis
Journal:  Histopathology       Date:  1995-09       Impact factor: 5.087

10.  Cystosarcoma phyllodes--Asian variations.

Authors:  C L Chua; A Thomas; B K Ng
Journal:  Aust N Z J Surg       Date:  1988-04
View more
  12 in total

1.  Full-thickness chest-wall resection followed by thorax reconstruction for recurrent malignant phyllodes tumor.

Authors:  Tokiko Ito; Ken-ichi Ito; Toshihiro Okada; Koichi Murayama; Toru Hanamura; Toshiharu Kanai; Kazuma Maeno; Yasuhiro Mochizuki; Ryoichi Kondo; Jun Amano; Yoshiro Osada; Koji Asano
Journal:  Int J Clin Oncol       Date:  2010-08-19       Impact factor: 3.402

Review 2.  Delayed cardiac metastasis from phyllodes breast tumor presenting as cardiogenic shock.

Authors:  Naveen Garg; Nagaraja Moorthy; Surendra K Agrawal; Santanu Pandey; Niraj Kumari
Journal:  Tex Heart Inst J       Date:  2011

3.  Stromal sarcoma of the breast with lung metastases showing a clinical complete response to doxorubicin plus ifosfamide treatment: report of a case.

Authors:  Aiko Sueta; Yutaka Yamamoto; Katsuhiko Inoue; Kazumi Kuriwaki; Hirotaka Iwase
Journal:  Surg Today       Date:  2011-07-20       Impact factor: 2.549

4.  Phyllodes tumor of the breast: the challenge persists.

Authors:  Shih-Ping Cheng; Yuan-Ching Chang; Tsang-Pai Liu; Jie-Jen Lee; Chi-Yuan Tzen; Chien-Liang Liu
Journal:  World J Surg       Date:  2006-08       Impact factor: 3.352

5.  Largest phyllodes tumor- case report and brief review article.

Authors:  Tarun Kumar; Mahesh D Patel; Rexeena Bhargavan; Prabhat Kumar; Mahesh H Patel; Kiran Kothari; Bina Brahmbhatt
Journal:  Indian J Surg Oncol       Date:  2011-07-15

6.  Gastric outlet obstruction caused by a pyloric submucosal fibroepithelial tumour.

Authors:  Jj McCombie; K Shahzad; Jr Pinto; S Kanwar
Journal:  J Surg Case Rep       Date:  2011-09-01

7.  Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin.

Authors:  Yngvar Fløisand; Klaus Beiske; Geir Erland Tjønnfjord; Dag Heldal; Bodil Bjerkehagen; Mona-Elisabeth Revheim; Sverre Heim; Oyvind Sverre Bruland; Kirsten Sundby Hall; Anne Tierens; Jan Delabie
Journal:  Case Rep Hematol       Date:  2013-12-17

8.  A case of large phyllodes tumor causing "rupture" of the breast: a unique presentation.

Authors:  Junaid Nabi; S M Quamrul Akhter; Fatema N Authoy
Journal:  Case Rep Oncol Med       Date:  2013-05-14

9.  A giant phyllodes tumor causing ulceration and severe breast disfigurement: case report and review of giant phyllodes.

Authors:  Mohammed A Sbeih; Ryan Engdahl; Marina Landa; Oreoluwa Ojutiku; Norman Morrison; Hector Depaz
Journal:  J Surg Case Rep       Date:  2015-12-24

10.  Giant malignant phyllodes tumor of the breast: A rare case report and literature review.

Authors:  Min Liu; Shuo Yang; Bin Liu; Liang Guo; Xueying Bao; Bailong Liu; Lihua Dong
Journal:  Oncol Lett       Date:  2016-05-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.